Country Profile

Moldova

Moldova is an emerging destination for Indian pharmaceutical exports — $4.43M in FY 2025–26. Medicines accounts for 68% of shipments, with vaccines contributing $462K.

🇲🇩 $4.43M · 0.9× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$4.43M
Exports FY2025–26 DGCIS
0.9×
Growth FY2015→2026
68%
Medicines Share
5
Product Categories Supplied
12
Years of Trade Data
Moldova is an emerging destination for Indian pharmaceutical exports — $4.43M in FY 2025–26. Medicines accounts for 68% of shipments, with vaccines contributing $462K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $3.01M (68.0%) Vaccines $462K (10.4%) Surgical & Hospital Supplies $451K (10.2%) Medicine Ingredients $427K (9.6%) Traditional & Herbal $78K (1.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Moldova in the RBI overseas direct investment dataset (2011–2026).